Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
NCT01810315
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
HIV Prevention
Interventions
DRUG:
TFV 1% gel
DRUG:
Estradiol vaginal cream
Sponsor
CONRAD